论文部分内容阅读
比较射频联合全身化疗和单独射频治疗肝肿瘤的坏死范围及安全性。分析 6 3例原发性和转移性肝癌患者 ,其中 2 8例接受经射频联合全身化疗治疗 ,另外 35例接受单独射频治疗。两组治疗疗效均由治疗后一个月的螺旋CT增强扫描评估。相对大肝癌组中联合化疗和单独射频两组的坏死范围有显著统计学差异 ;各组的安全性指标均无显著统计学差异。射频治疗肝肿瘤是安全有效的 ,与单独射频毁损治疗相比较 ,联合全身化疗后射频毁损治疗在治疗相对大肝癌时能增大肿瘤坏死范围 ,并且比较安全
Comparison of radiofrequency combined with systemic chemotherapy and radiofrequency alone for the treatment of liver tumor necrosis and safety. Sixty-three patients with primary and metastatic HCC were analyzed, of whom 28 received radiofrequency combined with systemic chemotherapy and the other 35 received radiofrequency alone. The efficacy of both groups was evaluated by spiral CT scan one month after treatment. There was significant difference in the range of necrosis between the two groups in combination chemotherapy and radiofrequency alone in the group of relatively large hepatocellular carcinoma. There was no significant difference in the safety of each group. Radiofrequency treatment of liver tumors is safe and effective, compared with the treatment of radiofrequency ablation alone, combined with radiofrequency ablation after systemic chemotherapy in the treatment of relatively large liver cancer can increase the scope of tumor necrosis, and more secure